TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 2.20nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 2.70nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: <40nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 42nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 57nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 59nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 60nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 70nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 77nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 80nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 84nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 100nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 100nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 160nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 170nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 190nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 220nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 220nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 260nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 270nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 350nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 410nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 430nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 470nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 470nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 530nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 550nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 560nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 670nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 690nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 740nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 810nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 970nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 1.00E+3nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.01E+3nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 1.40E+3nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
TargetPhenylalanine--tRNA ligase alpha/beta subunit(Escherichia coli (Enterobacteria))
Astrazeneca R&D Boston
Astrazeneca R&D Boston
Affinity DataIC50: 1.40E+3nMpH: 8.0Assay Description:Compounds were solubilized in DMSO. Serial 2-fold dilutions covering two concentration ranges, 10 mM to 19.5 μM and 100 μM to 195 nM, were ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.44E+3nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair